tDCS study using brain scans in schizophrenia
Part of Mental health clinical trials.
This trial tests whether a non-invasive brain stimulation approach (tDCS) changes brain connections in people with schizophrenia. It also uses specialized scans to look for changes in the brain that could help explain how treatment works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must already be enrolled in the related tDCS parent study (REB# 103-2018)
- You’re 18 or older and have a DSM-5 diagnosis of schizophrenia or schizoaffective disorder
- You must be able to give consent (research staff will check decision-making ability)
- You must have been on a stable dose of your oral antipsychotic medicines (and other key meds) for at least 2 months, with no plan to change during the study
- You should NOT have certain conditions that could affect safety or scan results, like seizures history, unstable major medical/neurologic illness, or metal implants/pacemaker that prevent MRI
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if combining a gentle brain stimulation technique (tACS) with talk therapy (CBT for psychosis) can help reduce symptoms in people with schizophrenia. You would keep taking your usual medications throughout the study.
This trial tests whether a non-painful brain stimulation method (tDCS) can help people with schizophrenia who also have moderate-to-severe cannabis use disorder reduce or quit cannabis. It also involves MRI scanning to help study brain changes.
This study tests a noninvasive brain stimulation treatment (tDCS) to improve thinking and memory problems in people with early schizophrenia. If you qualify, you would receive the study treatment while continuing stable schizophrenia care.
This trial tests a type of brain stimulation called TMS to see if it can change brain connections that may be linked to symptoms. It might help people with schizophrenia or schizoaffective disorder who are stable on their current medications.
This study compares two types of mild brain stimulation—tACS and tDCS—to see if they can help reduce symptoms of schizophrenia. It is for people who have had moderate to severe symptoms for at least two years and are on stable medications.
This trial studies whether a noninvasive brain stimulation method (tDCS) can reduce cannabis cravings in people with schizophrenia who use cannabis often. It may help by lowering craving and improving control over cannabis use, but you must meet specific safety and medication-use requirements.
Hear when a new Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.